Therapy and clinical trials: metabolic syndrome and cardiovascular risk management.
Edavalath
Mahamood
M
Department of Diabetes & Endocrinology, University Hospital of Wales, Cardiff, UK. edmahamood@hotmail.com
Rees
Alan
A
D000328:Adult; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D002995:Clofibric Acid / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D024821:Metabolic Syndrome / Q000188:drug therapy*; D012306:Risk
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002995:Clofibric Acid